middle.news
Microba Accelerates Growth with Record Q4 Sales and Eyes FY26 Break-Even
9:06am on Tuesday 22nd of July, 2025 AEST
•
Healthcare
Read Story
Microba Accelerates Growth with Record Q4 Sales and Eyes FY26 Break-Even
9:06am on Tuesday 22nd of July, 2025 AEST
Key Points
Q4 FY25 MetaXplore test sales up 88% in Australia and 74% quarter-on-quarter in the UK
FY25 revenue reaches $15.67 million, a 30% increase year-on-year
Strategic shift away from legacy products towards core diagnostics and partnering for therapeutics
Promising clinical study results support diagnostic tests’ impact on gastrointestinal disease management
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Microba Life Sciences (ASX:MAP)
OPEN ARTICLE